top of page

Nikolaos Kroustalakis

Nephrologist

Dr Nikolaos Kroustalakis is a board-certified Nephrologist with special interest in Acute Kidney Injury and Chronic Kidney Disease, Glomerular Diseases, Nephrolithiasis, Renal Replacement Therapies, Hypertension and Polycystic Kidney Disease.

Dr Kroustalakis was born and raised in Heraklion.


He is a Medical School graduate of the Second University of Naples, Italy. After successful participation in state exams of the Second University of Naples, he was granted license in practicing Medicine and Surgery.


After completing his studies, he started his residency in Internal Medicine, initially, at the Naval Hospital of Crete and continued at the General Hospital of Ierapetra. He served as a general practitioner during his compulsory rural service in the Leukogia community clinic, Drama Macedonia. Dr Kroustalakis continued his residency in Nephrology at Nephrology Department, University Hospital of Heraklion. Following board certification in Nephrology in 2009, he worked as Consultant Nephrologist of Greek National Health Service. Since December 2023 he has been working as a consultant in Nephrology Department at the German Medical Institute in Limassol.

dct-VhrachimisAl.jpg
Education / Academic Experience

  • 1999: Barchelor in Medicine, Second University of Naples, Italy.

  • 2005: 14th International Vicenza Course on Hemodialysis, Vicenza, Italy

  • 2006 and 2010: Harvard Nephrology Course, Boston,USA

  • 2008: “The Official ASN 13th Annual Board Review Course and Update”, San Francisco, USA

  • 2011: PhD candidate, Medical School, University of Crete.

Professional Experience

  • 2000-2001: Resident physician in Internal Medicine during military service, Naval Hospital of Crete.

  • 2002-2003: Compulsory rural service as a general practitioner in the Leukogia community clinic, Kato Nevrokopi Primary Health Care Center, Drama Macedonia.

  • 2003-2004: Resident physician in Internal Medicine, General Hospital of Ierapetra Crete.

  • 2004-2005: Trust Doctor and Scientific Collaborator at the Nephrology Department, University Hospital of Heraklion.

  • 2005-2009: Resident physician, Nephrology Department, University Hospital of Heraklion.

  • 2009-2010: Consultant Nephrologist, Nephrology Department, Kefalonia General Hospital.

  • 2010-2011: Consultant Nephrologist, Nephrology Department, University Hospital of Heraklion.

  • 2011-2019: Consultant Nephrologist, Nephrology Department, “Venizeleio” General Hospital of Heraklion.

  • 2019-2023: Consultant Nephrologist, Nephrology Department, University Hospital of Heraklion.

    Head of Peritoneal Dialysis Unit and responsible of the Polycystic Kidney Disease Clinic.

  • 2023-today: Consultant Nephrologist, German Medical Institute, Limassol.

Publications

  1. Listeria Monocytogenes Peritonitis in a Peritoneal Dialysis Patient with Severe Heart Failure. Konstantinos Stylianou, Andrew Passam, Antonios Papoutsakis, Kostas Perakis, Nikolaos Kroustalakis, Eugene Daphnis. Kidney (2008) 17:238-240.

  2. Brugada syndrome in patient with tonsillitis. M. Foukarakis, P Ioannidis, N Kroustalakis, A Kalogerakis, G Papailiakis, P Stasinos. Heart & Vessel (Greek Edition), January-February 2008, ΧΙΙΙ, 1, p57-62.

  3. Long-Term Complication Rates and Survival of Peritoneal Dialysis Catheters: The Role of Percutaneous Versus Surgical Placement. Kostas E. Perakis, Kostas G. Stylianou, John P. Kyriazis, Vasiliki N. Mavroeidi, Irene G. Katsipi, Eleftheria A. Vardaki, Ioannis G. Petrakis, Spyros Stratigis, Nikos G. Kroustalakis, Athanasios K. Alegakis, Eugene K. Daphnis. Seminars in Dialysis (2009) Volume 22 , Issue 5 , Pages 569 -575.

  4. Crescentic glomerulonephritis associated with vascular endothelial growth factor (VEGF) inhibitor and biphosphonate administration. Kostas Stylianou, Eirini Lioudaki, Elisavet Papadimitraki, George Kokologiannakis, Nikos Kroustalakis, Christina Liotsi, Konstantinos Giannakakis, Vasilios Georgoulias, Eugenios Daphnis. Nephrology Dialysis Transplantation (2011) 0: 1-3

  5. Rapamycin induced ultrastructural and molecular alterations in glomerular podocytes in healthy mice. Stylianou K, Petrakis I, Mavroeidi V, Stratakis S, Kokologiannakis G, Lioudaki E, Liotsi C, Kroustalakis N, Vardaki E, Stratigis S, Perakis K, Kyriazis J, Nakopoulou L, Daphnis E. Nephrology Dialysis Transplantation 2012;27(8):3141-8.

  6. Preoperative Albuminuria and Intraoperative Chloride Load: Predictors of Acute Kidney Injury Following Major Abdominal Surgery. Diamantina Marouli, Kostas Stylianou , Eleftherios Papadakis, Nikolaos Kroustalakis,Stavroula Kolyvaki, Georgios Papadopoulos, Christos Ioannou, Alexandra Papaioannou,Eugene Daphnis, Dimitris Georgopoulos and Helen Askitopoulou. J. Clin. Med. 2018, 7, 431; doi:10.3390/jcm7110431

  7. The p.Pro482Ala Variant in the CNNM2 Gene Causes Severe Hypomagnesemia Amenable to Treatment with Spironolactone. Petrakis I, Drosataki E, Stavrakaki I, Dermitzaki K, Lygerou D, Konidaki M, Pleros C, Kroustalakis N, Maragkou S, Androvitsanea A, Stylianou I, Zaganas I, Stylianou K.Int J Mol Sci. 2022 Jun 30;23(13):7284

  8. Tubulointerstitial Nephritis and Uveitis Syndrome: A Report of 6 Cases with Renal Biopsy and Electron Microscopy Evaluation. Palamaris K, Stylianou K, Destouni M, Stofas A, Theodoropoulou H, Kroustalakis N, Dermitzaki EK, Petrakis I, Pleros C, Theochari I, Sarantis P, Paliouras C, Gakiopoulou H. Nephron. 2024;148(4):204-214.

Studies

  • Participation in clinical studies

    Investigator in clinical trials on new therapies of renal diseases (Omeros, SHP647-301 etc).

  • Participation in closed expert advisory committees (Advisory)

    “Parsabiv (etelcalcetide) a new IV therapy for Secondary Hyperparathyroidism (SHPT) patient”, Amgen. November 2017, Heraklion.

Professional Memberships

  • Heraklion Medical Association

  • Limassol Medical Association

  • Hellenic Society of Nephrology

  • International Society of Nephrology

  • European Renal Association

  • Society for the Study of Hereditary Kidney Diseases of Crete


bottom of page